<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Intrauterine adhesions: Clinical manifestation and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Intrauterine adhesions: Clinical manifestation and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Intrauterine adhesions: Clinical manifestation and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marcelle I Cedars, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Amanda Adeleye, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert L Barbieri, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen Eckler, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 12, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intrauterine adhesions (IUAs) are bands of fibrous tissue that form in the endometrial cavity, often in response to a uterine procedure. Disease severity can range from thin strings of tissue to complete obliteration of the cavity. Clinical sequelae include infertility, recurrent pregnancy loss, menstrual abnormalities, and pain. Clinical challenges include primary prevention of adhesions and prevention of recurrent adhesions after surgical treatment.
        </p>
        <p>
         This topic will discuss the etiology, pathogenesis, clinical presentation, diagnosis, and management of IUA. Related topics on dilation and curettage and postpartum hemorrhage as well as general principles of the evaluation of amenorrhea, infertility, or recurrent pregnancy loss are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3273.html" rel="external">
          "Dilation and curettage"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6710.html" rel="external">
          "Overview of postpartum hemorrhage"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7402.html" rel="external">
          "Evaluation and management of secondary amenorrhea"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5445.html" rel="external">
          "Female infertility: Evaluation"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5436.html" rel="external">
          "Recurrent pregnancy loss: Evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H505874427">
         <span class="h1">
          DEFINITION AND TERMINOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         IUAs, or intrauterine synechiae, is a condition in which scar tissue develops within the uterine cavity. IUAs that are accompanied by symptoms (eg, infertility, amenorrhea) are referred to as Asherman syndrome [
         <a href="#rid1">
          1-3
         </a>
         ]. The terms are often used interchangeably. The degree of adhesion formation and the impact of the adhesions on the contour of uterine cavity vary greatly. Minimal disease is characterized by thin strands of tissue stretched across the uterine cavity while severe disease is characterized by complete obliteration of the cavity, with the anterior wall of the uterus densely adherent to the posterior wall.
        </p>
        <p class="headingAnchor" id="H29099153">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The true prevalence of IUAs is difficult to establish, in part because the condition is uncommon in the general population, often asymptomatic, and requires an invasive procedure for diagnosis. In addition, few studies prospectively evaluate for postprocedure adhesions [
         <a href="#rid4">
          4
         </a>
         ]. Estimates of the prevalence range from 1.5 percent as an incidental finding at hysterosalpingogram to 21.5 percent of women with a history of postpartum uterine curettage [
         <a href="#rid3">
          3
         </a>
         ]. In a meta-analysis that included over 900 women evaluated with hysteroscopy within 12 months following a spontaneous abortion (86 percent underwent curettage), the prevalence of IUAs was 19.1 percent [
         <a href="#rid5">
          5
         </a>
         ]. Even relatively minor surgeries can be complicated by IUAs (
         <a class="graphic graphic_table graphicRef96049" href="/z/d/graphic/96049.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          ETIOLOGY AND RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         IUAs appear to result from trauma to the basalis layer of the endometrium (
         <a class="graphic graphic_figure graphicRef54487" href="/z/d/graphic/54487.html" rel="external">
          figure 1
         </a>
         ). The basalis layer appears to be most susceptible to damage in the first four postpartum or postabortal weeks. Emerging data suggest that angiogenic factors such as vascular endothelial growth factor (VEGF) are important modulators of endometrial stromal fibrosis [
         <a href="#rid7">
          7
         </a>
         ]. VEGF is downregulated in the endometrial tissue of women with Asherman's syndrome. Subsequent tissue healing on opposing surfaces of the uterus may eventually fuse to produce tissue bridges. These IUAs range from filmy adhesions composed of endometrial tissue to dense adhesions consisting entirely of connective tissue. The resulting adherence of the uterine walls may result in partial or complete obliteration of the uterine cavity. In addition, vascularization may be compromised due to endometrial damage and scarring [
         <a href="#rid8">
          8
         </a>
         ]. These changes account for menstrual abnormalities, frequent dysmenorrhea, infertility, and recurrent pregnancy loss.
        </p>
        <p>
         Risk factors include intrauterine processes that have the potential to damage the basalis layer, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pregnancy
         </strong>
         – While it is impossible to separate the impact of pregnancy-related changes from the risk of an intrauterine procedure on the development of subsequent IUAs, pregnancy appears to be an independent risk factor distinct from intrauterine surgery. In a study of 85 women who underwent operative resection of IUAs, 65 percent (n = 55) had a previously undergone a pregnancy-related intrauterine procedure while 12 percent (n = 10 women) had undergone a procedure on a nongravid uterus, most commonly hysteroscopic surgery [
         <a href="#rid9">
          9
         </a>
         ]. A comparison of the reported incidence of IUAs following procedures in both gravid and nongravid uteri is presented in the table (
         <a class="graphic graphic_table graphicRef113893" href="/z/d/graphic/113893.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid5">
          5,10-17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition, the duration of pregnancy and the timing of pregnancy relative to the procedure appear to impact the risk of IUA formation. At least one study has reported an increased prevalence of IUAs among patients who underwent curettage after a pregnancy loss at a more advanced gestational age compared with earlier pregnancy loss [
         <a href="#rid18">
          18
         </a>
         ]. A different study reported a higher risk of adhesion formation in women who underwent postpartum curettage two to four weeks after delivery compared with early in the postpartum period [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Repeated curettage following pregnancy loss also increases the risk of developing adhesions, but again it is unclear how much of the risk is related to the gravid state versus repetitive intrauterine trauma. In a meta-analysis of 10 prospective studies including 912 women who underwent hysteroscopic evaluation within 12 months of miscarriage, the pooled prevalence of IUAs was nearly 20 percent [
         <a href="#rid5">
          5
         </a>
         ]. Women who had &gt;1 miscarriage had nearly double the odds of IUAs compared with women who had one miscarriage, which was similar to the odds of IUAs for women who had &gt;1 or 1 curettage procedure. Of the 47 women who had expectant or medical management (ie, no intrauterine manipulation), no IUAs were noted. However, the possibility of forming IUAs after expectant or medical management cannot be excluded based on the small number of women studied and lack of randomly assigned study design.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Possible explanations for uterine susceptibility to IUA formation following pregnancy include the low-estrogen state associated with the postpartum or postabortion time period, antagonistic effects from elevated prolactin levels associated with breastfeeding, or postpregnancy physiologic changes that make the basalis layer more susceptible to injury [
         <a href="#rid9">
          9,20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intrauterine procedure
         </strong>
         s – Intrauterine manipulation, separate from pregnancy, is associated with the development of IUAs as demonstrated by the formation of adhesions after procedures such as myomectomy or curettage in nongravid uteri [
         <a href="#rid10">
          10,11,17,21-25
         </a>
         ]. Some studies suggest that removal of multiple fibroids at the time of hysteroscopic myomectomy is associated with higher risk of IUAs than removal of one fibroid [
         <a href="#rid23">
          23,24
         </a>
         ], while other studies report no differences in the risk of adhesions with a single or multiple hysteroscopic myomectomy [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         While intrauterine device (IUD) use has been associated with adhesion formation, the data are mainly limited to case reports and IUD use does not appear to be a major cause of IUAs [
         <a href="#rid26">
          26
         </a>
         ]. As discussed below, IUDs can be used to prevent adhesion reformation after surgical resection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inflammation or infection
         </strong>
         – In a study assessing chronic endometritis in women with known IUAs, 35 percent of women (29 of 82) had chronic endometritis confirmed by histology [
         <a href="#rid27">
          27
         </a>
         ]. However, it is not known if the chronic endometritis was the cause or the sequelae of the adhesions. The role of postpartum or postabortal infection in adhesion formation is also unclear as data are limited. A study that evaluated 28 women with significant postcesarean delivery endometritis by hysteroscopy reported the frequency of adhesions in these women was similar to that in controls without postcesarean infection [
         <a href="#rid28">
          28
         </a>
         ]. Another study reported a nonsignificant increase in adhesion formation when dilation and curettage was performed in the presence of concurrent infection [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In contrast, genital tuberculosis is associated with IUAs, which are often severe, with complete obliteration of the uterine cavity [
         <a href="#rid30">
          30,31
         </a>
         ]. These patients typically present with amenorrhea and cyclic pelvic pain. The adhesions are believed to form secondary to chronic inflammation of the endometrium. (See
         <a class="medical medical_review" href="/z/d/html/5462.html" rel="external">
          "Endometritis unrelated to pregnancy", section on 'Tuberculous endometritis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Uterine compression sutures
         </strong>
         – Uterine compression sutures (eg, B-Lynch suture) used to treat severe postpartum hemorrhage have been associated with the development of IUAs. In four retrospective reviews, IUAs were diagnosed in 19 to 27 percent of women who received uterine compression sutures to treat postpartum hemorrhage [
         <a href="#rid32">
          32-35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6712.html" rel="external">
          "Postpartum hemorrhage: Management approaches requiring laparotomy", section on 'B-Lynch suture'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6712.html" rel="external">
          "Postpartum hemorrhage: Management approaches requiring laparotomy", section on 'Atony'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4440.html" rel="external">
          "Postpartum hemorrhage: Use of an intrauterine hemorrhage-control device"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          CLINICAL PRESENTATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The classic clinical presentation of IUAs is of an ovulatory woman who develops secondary amenorrhea or hypomenorrhea after an intrauterine procedure, particularly if the procedure was performed on a gravid uterus [
         <a href="#rid4">
          4
         </a>
         ]. Pregnancy-related intrauterine procedures occurring prior to symptom onset have been reported in 91 to 99.8 percent of women treated for Asherman syndrome [
         <a href="#rid36">
          36,37
         </a>
         ]. Alternately, some women are identified as likely having IUAs by imaging studies ordered for the evaluation of infertility (eg,
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         infusion sonohysterogram [SIS] (
         <a class="graphic graphic_diagnosticimage graphicRef64518" href="/z/d/graphic/64518.html" rel="external">
          image 1
         </a>
         ) or hysterosalpingogram [HSG] (
         <a class="graphic graphic_diagnosticimage graphicRef98572" href="/z/d/graphic/98572.html" rel="external">
          image 2
         </a>
         )). (See
         <a class="local">
          'Imaging studies'
         </a>
         below.)
        </p>
        <p>
         Typical symptoms associated with IUAs include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Abnormal uterine bleeding
         </strong>
         – Abnormal, or changed, menstrual bleeding patterns are reported by 70 to 95 percent of women with IUAs [
         <a href="#rid3">
          3,36
         </a>
         ]. In a literature review of over 2900 patients with IUAs, the abnormal uterine bleeding patterns were the following: amenorrhea (37 percent), light bleeding (31 percent), normal menses (5 percent), and menorrhagia (1 percent) [
         <a href="#rid3">
          3
         </a>
         ]. Patients are more likely to present with secondary amenorrhea than with primary amenorrhea, since endometrial damage is rare prior to menarche. While hypomenorrhea is a poorly defined term, we define it here as menstrual flow that is light (&lt;5 mL) or shortened (&lt;5 days) [
         <a href="#rid38">
          38
         </a>
         ]. However, volume of uterine bleeding is difficult to measure and the interpretation of light menses is typically based on the patient's report of a noticeable decrease in volume or a volume that requires fewer or lighter tampons or pads.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Of note, adhesions can also be asymptomatic. In one report, up to three percent of women with severe adhesions noted cyclic, pain-free menses of normal volume and duration [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infertility
         </strong>
         – Infertility has been reported in 7 to 40 percent of women with IUAs [
         <a href="#rid3">
          3,36
         </a>
         ]. IUAs are one of the differential diagnoses for the etiology of female infertility, and may be discovered when a HSG or hysteroscopy is performed as part of the standard infertility evaluation. Possible mechanisms by which IUAs could contribute to infertility include blockage of sperm [
         <a href="#rid3">
          3
         </a>
         ] or injury/destruction of the endometrium that prevents implantation of the blastocyst [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5445.html" rel="external">
          "Female infertility: Evaluation", section on 'Assessment of the uterine cavity'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cyclic pelvic pain or dysmenorrhea
         </strong>
         – Cyclic pelvic pain, which has been reported by 3.5 percent of women with IUAs, is likely due to obstruction of menstrual flow and/or hematometra [
         <a href="#rid39">
          39
         </a>
         ]. Thus, pain is typically associated with amenorrhea or hypomenorrhea. These symptoms are similar to those in women who undergo endometrial ablation and who have both intrauterine scar tissue induced by the procedure and residual functional endometrium. (See
         <a class="medical medical_review" href="/z/d/html/3316.html" rel="external">
          "Overview of endometrial ablation", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Recurrent pregnancy loss
         </strong>
         – Recurrent pregnancy loss may occur in women with IUAs due to abnormalities of implantation in areas of denuded endometrium or insufficient vascularization. In one study of 85 women who underwent hysteroscopic lysis of IUAs, 13 percent had recurrent pregnancy loss (defined as ≥3 losses) [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5437.html" rel="external">
          "Recurrent pregnancy loss: Definition and etiology", section on 'Intrauterine adhesions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidental finding
         </strong>
         – IUAs may be found as an incidental finding in a woman who undergoes a pelvic ultrasound,
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         infusion SIS, HSG, or hysteroscopy for another indication (eg, infertility, abnormal uterine bleeding). As asymptomatic women do not routinely undergo hysteroscopy or pelvic imaging, the prevalence of asymptomatic IUAs is not known. (See
         <a class="local">
          'Hysteroscopy'
         </a>
         below and
         <a class="local">
          'Imaging studies'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H29099245">
         <span class="h1">
          DIAGNOSTIC EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H1936239619">
         <span class="h2">
          Our approach
         </span>
         <span class="headingEndMark">
          —
         </span>
         The main components of the diagnostic evaluation for IUAs are the medical history and uterine cavity evaluation. We take the following approach:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The assessment begins with a history. We pay particular attention to menstrual symptoms and any pregnancies or intrauterine procedures that occurred prior to the onset of symptoms.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physical examination is performed next, which is typically normal. Some patients may have undergone a prior pelvic ultrasound as part of their evaluation for infertility or menstrual dysfunction. In some cases, a pelvic ultrasound may demonstrate an unusually thin endometrial lining, in the peri- or postovulatory phase. A pelvic ultrasound is not required for the diagnosis of IUAs.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The next steps are determined by the likelihood of adhesive disease:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Women with a high suspicion of IUAs go directly to endometrial evaluation, typically with hysteroscopy. While hysteroscopy is the gold standard, a
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         infusion sonohysterogram (SIS) can also be used to evaluate the uterine cavity [
         <a href="#rid4">
          4,40
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Women with a low risk of IUA ultimately often undergo hysteroscopy, but may have additional testing prior. As an example, for women with a primary complaint of oligomenorrhea or amenorrhea and suspicion of IUAs, we first perform SIS or office ultrasound to assess the endometrial thickness. A thin endometrial lining (&lt;4 mm) can be suggestive of IUAs.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H29099537">
         <span class="h2">
          History
         </span>
         <span class="headingEndMark">
          —
         </span>
         The key components of the medical history include ascertainment of symptoms (menstrual change, infertility, or dysmenorrhea), history of prior pregnancies, and history of prior uterine procedures. For asymptomatic women, we focus on IUA risk factors such as uterine instrumentation and pelvic infection (eg, endometritis). (See
         <a class="local">
          'Clinical presentation'
         </a>
         above and
         <a class="local">
          'Etiology and risk factors'
         </a>
         above.)
        </p>
        <p>
         In addition, in women from regions with endemic tuberculosis, we advise evaluating for pelvic tuberculosis. Some clinicians propose screening at-risk patients for tuberculosis. For those who screen positive, endometrial biopsy is advised [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5462.html" rel="external">
          "Endometritis unrelated to pregnancy", section on 'Tuberculous endometritis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H24757535">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bimanual pelvic examination will not reveal IUAs. We do not routinely probe the cervix at the time of physical examination. However, if cervical dilation is required for another indication during evaluation (eg, endometrial biopsy), practitioners may note difficulty passing a dilator during the procedure due to obstructive adhesions.
        </p>
        <p class="headingAnchor" id="H3399236593">
         <span class="h2">
          Ultrasound
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ultrasound is a very useful adjunct during the early evaluation of patients with amenorrhea and/or a history suggestive of IUAs. A very thin endometrium following amenorrhea and/or endometrial irregularity with hyperechoic regions may be suggestive of IUAs. However, while ultrasound findings can be suggestive of IUAs, this study is not definitive.
        </p>
        <p class="headingAnchor" id="H509071">
         <span class="h2">
          Estrogen/progestin withdrawal test
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not routinely perform an estrogen/progestin withdrawal test for women suspected of having IUAs because the test takes additional time and only further delays the diagnosis. An estrogen-progestin withdrawal test is a two-month process during which the patient receives progestin alone followed by estrogen and progestin. The test is appropriate for some women being evaluated for amenorrhea. (See
         <a class="medical medical_review" href="/z/d/html/7402.html" rel="external">
          "Evaluation and management of secondary amenorrhea", section on 'Normal laboratory results and history of uterine instrumentation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H29099252">
         <span class="h2">
          Hysteroscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hysteroscopy allows direct visualization of the presence, extent, and morphologic characteristics of IUAs (
         <a class="graphic graphic_diagnosticimage graphicRef72065" href="/z/d/graphic/72065.html" rel="external">
          image 3
         </a>
         ). In addition, the uterine cavity can be assessed to determine how much of the endometrial surface appears viable. Hysteroscopy also allows for simultaneous diagnosis and treatment. Hysteroscopic findings are the basis for most classification systems [
         <a href="#rid29">
          29,42-47
         </a>
         ]. (See
         <a class="local">
          'Classification'
         </a>
         below.)
        </p>
        <p>
         Adhesions may arise from the endometrium, myometrium, or connective tissue. They vary in size from thin and fragile to thick and dense, with the ends broader than the middle. They may occur at the margins of the endometrial cavity or diffusely; in severe cases, they completely obliterate the cavity. Marginal adhesions may appear crescent-shaped or like a curtain. Mucosal adhesions are the same color as the endometrium and fragile, whereas fibrous adhesions are pale and strong. IUAs due to tuberculosis tend to give the endometrial cavity a honeycomb appearance.
        </p>
        <p>
         Hysteroscopy, with lysis of adhesions as indicated, can be performed in an office or operating room setting [
         <a href="#rid48">
          48
         </a>
         ]. This allows diagnosis and treatment in a single procedure and decreases the probability of trauma to the surrounding endometrium. (See
         <a class="medical medical_review" href="/z/d/html/3278.html" rel="external">
          "Overview of hysteroscopy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2085572092">
         <span class="h3">
          Classification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hysteroscopic findings are the basis for most classification systems [
         <a href="#rid29">
          29,42-47
         </a>
         ]. While several societies endorse using a classification system because the prognosis is correlated with disease severity, at least one review concluded that the lack of trials comparing the various systems prevents the endorsement of any one system [
         <a href="#rid48">
          48
         </a>
         ]. A summary of the various systems is presented in the table (
         <a class="graphic graphic_table graphicRef113868" href="/z/d/graphic/113868.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p>
         Two of the more commonly used systems are from the American Society for Reproductive Medicine (ASRM, previously the American Fertility Society) and the European Society for Hysteroscopy. [
         <a href="#rid3">
          3,29
         </a>
         ]. The ASRM system consists of three stages of disease, based upon the extent of cavity involvement of the uterine cavity (&lt;1/3, 1/3 to 2/3, &gt;2/3), the type of adhesion seen at the time of hysteroscopy (filmy, filmy and dense, dense), and the patient's menstrual pattern (normal, hypomenorrhea, amenorrhea) (
         <a class="graphic graphic_figure graphicRef96054" href="/z/d/graphic/96054.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid29">
          29
         </a>
         ]. The European Society for Hysteroscopy system grades adhesions based on the operator's ability to disrupt them with the hysteroscope and visualize the tubal ostia as well as the amount of scarring of the uterine cavity (
         <a class="graphic graphic_table graphicRef96055" href="/z/d/graphic/96055.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H29099259">
         <span class="h2">
          Imaging studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         SIS (
         <a class="graphic graphic_diagnosticimage graphicRef64518" href="/z/d/graphic/64518.html" rel="external">
          image 1
         </a>
         ), hysterosalpingogram (HSG) (
         <a class="graphic graphic_diagnosticimage graphicRef98572" href="/z/d/graphic/98572.html" rel="external">
          image 2
         </a>
         ), and magnetic resonance imaging (MRI) have limited roles in the diagnosis of IUAs [
         <a href="#rid49">
          49
         </a>
         ]. While these imaging studies can detect adhesions, they do not provide complete information about the extent and appearance of adhesions or the condition of the endometrium compared with hysteroscopy [
         <a href="#rid4">
          4
         </a>
         ]. These studies may help the practitioner decide whether or not to perform hysteroscopy and, based on the surgeon's skill and available equipment, the appropriate setting in which to perform hysteroscopy with surgical correction (ie, office setting, outpatient operating room, or hospital-based operating room). (See
         <a class="local">
          'Hysteroscopy'
         </a>
         above.)
        </p>
        <p>
         Studies of the performance of these tests for detecting IUAs include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a systematic review of 20 studies comparing SIS with hysteroscopy for the detection of IUAs, the pooled sensitivity and specificity of SIS were 0.82 and 0.99 (95% CIs 0.65-0.93 and 0.98-1.00, respectively) [
         <a href="#rid40">
          40
         </a>
         ]. The positive and negative likelihood ratios were 34.58 (95% CI 16.68-71.70) and 0.36 (95% CI 0.22-0.58).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a prospective study of 65 infertile women that compared HSG, SIS, and transvaginal ultrasonography (TVUS) with hysteroscopy, HSG and SIS were equally sensitive for diagnosing IUAs (both detected 3 of 4 cases, sensitivity 75 percent) [
         <a href="#rid50">
          50
         </a>
         ]. TVUS alone appeared to have limited usefulness in this series (detected 0 of 4 cases).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A retrospective study of 78 women that used hysteroscopy as the reference standard reported that HSG had a sensitivity of 81.2 percent and specificity of 80.4 percent for detecting IUAs [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Advantages of SIS compared with HSG are that it does not involve radiation and some clinicians are able to perform the study in an office setting. HSG, on the other hand, must be performed in a radiology suite. The advantage of HSG is the ability to evaluate tubal patency, if this is indicated, although newer techniques for SIS that involve infusion of a water/air combination may improve assessment of tubal patency with SIS [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         Pelvic ultrasound alone is not generally a useful test to assess this condition, although adhesions may be detected by highly experienced ultrasonographers [
         <a href="#rid53">
          53,54
         </a>
         ]. A thin and irregular endometrium (sometimes referred to as "skip lesions") may represent IUAs [
         <a href="#rid55">
          55
         </a>
         ]. MRI has been used for women with cervical stenosis that prevents hysteroscopy, HSG, or SIS, but data on this technique are mainly limited to case studies [
         <a href="#rid39">
          39,56-58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Direct visualization of IUAs with hysteroscopy is the gold standard for the diagnosis [
         <a href="#rid42">
          42,43,48,50
         </a>
         ]. While imaging studies such as hysterosalpingography (HSG) and
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         infusion sonohysterography (SIS) can detect adhesions, the sensitivity is lower compared with hysteroscopy, and therefore negative imaging studies cannot exclude adhesions [
         <a href="#rid50">
          50
         </a>
         ]. In a prospective study of 65 infertile women comparing different imaging techniques with hysteroscopy as the standard, both HSG and SIS had a 75 percent sensitivity for the detection of IUAs and positive predictive values of 50 and 43 percent, respectively [
         <a href="#rid50">
          50
         </a>
         ]. (See
         <a class="local">
          'Imaging studies'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H29099544">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of IUAs depends upon the presenting symptoms.
        </p>
        <p>
         For women with amenorrhea or hypomenorrhea, the patient should be evaluated for an endocrine etiology. However, as part of this evaluation, if an estrogen/progestin withdrawal test does not result in bleeding, then IUAs, a cervical or uterine anomaly, or cervical stenosis are the likely etiologies. Even in the setting of a positive withdrawal test, IUAs should be considered in the differential diagnosis of hypomenorrhea, especially in women with infertility. (See
         <a class="local">
          'Estrogen/progestin withdrawal test'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5418.html" rel="external">
          "Congenital uterine anomalies: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5428.html" rel="external">
          "Benign cervical lesions and congenital anomalies of the cervix"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7402.html" rel="external">
          "Evaluation and management of secondary amenorrhea", section on 'Normal laboratory results and history of uterine instrumentation'
         </a>
         .)
        </p>
        <p>
         Cervical stenosis can frequently be differentiated from IUA by history, as cervical stenosis is often associated with cyclic pain that results from obstructed menstrual flow. As noted above, a failed attempt to pass an instrument (eg, cervical dilator or hysteroscope) through the external or internal cervical os may indicate cervical stenosis, but blind exploration of the cervical canal is not recommended in the office. Ultrasound guidance during cervical dilation or hysteroscopy with a 3 or 5 mm hysteroscopy without any prior dilation can directly visualize cervical stenosis and, once through the stenotic cervix, also evaluate the endometrial cavity.
        </p>
        <p>
         Uterine anomalies, such as a uterine septum, may also result in abnormal uterine bleeding, infertility, or recurrent pregnancy loss. However, the hysteroscopic appearance is significantly different. A uterine septum is located in the midline fundus and retracts with incision, while adhesions are rarely symmetrical and do not retract with incision, and thus require excision for complete removal. (See
         <a class="medical medical_review" href="/z/d/html/5418.html" rel="external">
          "Congenital uterine anomalies: Clinical manifestations and diagnosis", section on 'Septate or subseptate uterus'
         </a>
         .)
        </p>
        <p>
         For women with infertility or recurrent pregnancy loss, there are many potential etiologies. The evaluation for these conditions typically includes hysteroscopy, which would identify IUAs. (See
         <a class="medical medical_review" href="/z/d/html/5445.html" rel="external">
          "Female infertility: Evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5436.html" rel="external">
          "Recurrent pregnancy loss: Evaluation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1065063788">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117346.html" rel="external">
          "Society guideline links: Hysteroscopy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intrauterine adhesions (IUAs), or intrauterine synechiae, is a condition in which scar tissue develops within the uterine cavity. IUAs accompanied by symptoms (eg, infertility, amenorrhea) is also referred to as Asherman syndrome. (See
         <a class="local">
          'Definition and terminology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The prevalence of IUAs is difficult to establish because the condition is rare, can be asymptomatic, and is not typically assessed for in a prospective fashion. Estimates of the prevalence range from 1.5 percent as an incidental finding at hysterosalpingogram (HSG) to 21.5 percent of women with a history of postpartum uterine curettage. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         IUAs appear to result from trauma to the basalis layer of the endometrium (
         <a class="graphic graphic_figure graphicRef54487" href="/z/d/graphic/54487.html" rel="external">
          figure 1
         </a>
         ). The basalis layer appears to be most susceptible to damage in the first four postpartum or postabortal weeks. Trauma typically results from intrauterine procedures such as dilation and curettage, although inflammation, infection, and uterine compression sutures can play a role. (See
         <a class="local">
          'Etiology and risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clinical manifestations of severe intrauterine adhesive disease include menstrual irregularities (amenorrhea, hypomenorrhea), infertility, cyclic pain, recurrent pregnancy loss, and abnormal placentation. IUAs can also be an incidental finding in an otherwise asymptomatic women. (See
         <a class="local">
          'Clinical presentation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The diagnosis of IUAs is based upon visualization of IUAs directly by hysteroscopy. Imaging studies such as HSG or
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         infusion sonohysterogram can detect adhesions, but the sensitivity is lower compared with hysteroscopy and therefore a negative imaging study does not exclude adhesions. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         <strong>
          ACKNOWLEDGMENT
         </strong>
         — The UpToDate editorial staff acknowledges Yanett Anaya, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           ASHERMAN JG. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp 1950; 57:892.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ASHERMAN JG. Amenorrhoea traumatica (atretica). J Obstet Gynaecol Br Emp 1948; 55:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deans R, Abbott J. Review of intrauterine adhesions. J Minim Invasive Gynecol 2010; 17:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salazar CA, Isaacson K, Morris S. A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options. Curr Opin Obstet Gynecol 2017; 29:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hooker AB, Lemmers M, Thurkow AL, et al. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update 2014; 20:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           March CM. Asherman's syndrome. Semin Reprod Med 2011; 29:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lv H, Nan Z, Jiang P, et al. Vascular endothelial growth factor 165 inhibits pro-fibrotic differentiation of stromal cells via the DLL4/Notch4/smad7 pathway. Cell Death Dis 2019; 10:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen Y, Chang Y, Yao S. Role of angiogenesis in endometrial repair of patients with severe intrauterine adhesion. Int J Clin Exp Pathol 2013; 6:1343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu D, Li TC, Xia E, et al. Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome. Fertil Steril 2008; 89:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Touboul C, Fernandez H, Deffieux X, et al. Uterine synechiae after bipolar hysteroscopic resection of submucosal myomas in patients with infertility. Fertil Steril 2009; 92:1690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu X, Yuhan L, Dongmei S, et al. The incidence of post-operative adhesion following transection of uterine septum: a cohort study comparing three different adjuvant therapies. Eur J Obstet Gynecol Reprod Biol 2016; 201:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilman AR, Dewar KM, Rhone SA, Fluker MR. Intrauterine Adhesions Following Miscarriage: Look and Learn. J Obstet Gynaecol Can 2016; 38:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hooker A, Fraenk D, Brölmann H, Huirne J. Prevalence of intrauterine adhesions after termination of pregnancy: a systematic review. Eur J Contracept Reprod Health Care 2016; 21:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smorgick N, Barel O, Fuchs N, et al. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol 2014; 173:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hooker AB, Aydin H, Brölmann HA, Huirne JA. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertil Steril 2016; 105:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barel O, Krakov A, Pansky M, et al. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors? Fertil Steril 2015; 103:775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhandari S, Ganguly I, Agarwal P, et al. Effect of myomectomy on endometrial cavity: A prospective study of 51 cases. J Hum Reprod Sci 2016; 9:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adoni A, Palti Z, Milwidsky A, Dolberg M. The incidence of intrauterine adhesions following spontaneous abortion. Int J Fertil 1982; 27:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ERIKSEN J, KAESTEL C. The incidence of uterine atresia after post-partum curettage. A follow-up examination of 141 patients. Dan Med Bull 1960; 7:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           March CM. Management of Asherman's syndrome. Reprod Biomed Online 2011; 23:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Inany H. Intrauterine adhesions. An update. Acta Obstet Gynecol Scand 2001; 80:986.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Spiezio Sardo A, Mazzon I, Bramante S, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update 2008; 14:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taskin O, Sadik S, Onoglu A, et al. Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery. J Am Assoc Gynecol Laparosc 2000; 7:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang JH, Chen MJ, Wu MY, et al. Office hysteroscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas. Fertil Steril 2008; 89:1254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazzon I, Favilli A, Cocco P, et al. Does cold loop hysteroscopic myomectomy reduce intrauterine adhesions? A retrospective study. Fertil Steril 2014; 101:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kjer JJ. Asherman syndrome in a Danish population. Acta Obstet Gynecol Scand 2014; 93:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen Y, Liu L, Luo Y, et al. Prevalence and Impact of Chronic Endometritis in Patients With Intrauterine Adhesions: A Prospective Cohort Study. J Minim Invasive Gynecol 2017; 24:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polishuk WZ, Anteby SO, Weinstein D. Puerperal endometritis and intrauterine adhesions. Int Surg 1975; 60:418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions. Fertil Steril 1988; 49:944.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma JB, Roy KK, Pushparaj M, et al. Genital tuberculosis: an important cause of Asherman's syndrome in India. Arch Gynecol Obstet 2008; 277:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bukulmez O, Yarali H, Gurgan T. Total corporal synechiae due to tuberculosis carry a very poor prognosis following hysteroscopic synechialysis. Hum Reprod 1999; 14:1960.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poujade O, Grossetti A, Mougel L, et al. Risk of synechiae following uterine compression sutures in the management of major postpartum haemorrhage. BJOG 2011; 118:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasheed SM, Amin MM, Abd Ellah AH, et al. Reproductive performance after conservative surgical treatment of postpartum hemorrhage. Int J Gynaecol Obstet 2014; 124:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rathat G, Do Trinh P, Mercier G, et al. Synechia after uterine compression sutures. Fertil Steril 2011; 95:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ibrahim MI, Raafat TA, Ellaithy MI, Aly RT. Risk of postpartum uterine synechiae following uterine compression suturing during postpartum haemorrhage. Aust N Z J Obstet Gynaecol 2013; 53:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanstede MM, van der Meij E, Goedemans L, Emanuel MH. Results of centralized Asherman surgery, 2003-2013. Fertil Steril 2015; 104:1561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schenker JG, Margalioth EJ. Intrauterine adhesions: an updated appraisal. Fertil Steril 1982; 37:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod 2007; 22:635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu D, Wong YM, Cheong Y, et al. Asherman syndrome--one century later. Fertil Steril 2008; 89:759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seshadri S, El-Toukhy T, Douiri A, et al. Diagnostic accuracy of saline infusion sonography in the evaluation of uterine cavity abnormalities prior to assisted reproductive techniques: a systematic review and meta-analyses. Hum Reprod Update 2015; 21:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tal R, Lawal T, Granger E, et al. Genital tuberculosis screening at an academic fertility center in the United States. Am J Obstet Gynecol 2020; 223:737.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           March CM, Israel R, March AD. Hysteroscopic management of intrauterine adhesions. Am J Obstet Gynecol 1978; 130:653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol 1988; 158:1459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nasr AL, Al-Inany HG, Thabet SM, Aboulghar M. A clinicohysteroscopic scoring system of intrauterine adhesions. Gynecol Obstet Invest 2000; 50:178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamou J, Salat-Baroux J, Siegler AM. Diagnosis and treatment of intrauterine adhesions by microhysteroscopy. Fertil Steril 1983; 39:321.
          </a>
         </li>
         <li class="breakAll">
          Wamsteker K, De Blok SJ. Diagnostic hysteroscopy: Technique and documentation. In: Endoscopic surgery for gynecologists, Sutton C, Diamon M (Eds), Lippincott Williams &amp; Wilkins, New York 1995. p.263.
         </li>
         <li class="breakAll">
          Donnez J, Nisolle M. Hysteroscopic lysis of intrauterine adhesions (Asherman Syndrome). In: Atlas of Laser Operative Laparoscopy and Hysteroscopy, Donnez J (Ed), Press-Parthenon, New York 1994. p.305.
         </li>
         <li>
          <a class="nounderline abstract_t">
           AAGL Elevating Gynecologic Surgery. AAGL Practice Report: Practice Guidelines on Intrauterine Adhesions Developed in Collaboration With the European Society of Gynaecological Endoscopy (ESGE). J Minim Invasive Gynecol 2017; 24:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bekiesinska-Figatowska M. Magnetic resonance imaging of the female pelvis after Cesarean section: a pictorial review. Insights Imaging 2020; 11:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soares SR, Barbosa dos Reis MM, Camargos AF. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril 2000; 73:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roma Dalfó A, Ubeda B, Ubeda A, et al. Diagnostic value of hysterosalpingography in the detection of intrauterine abnormalities: a comparison with hysteroscopy. AJR Am J Roentgenol 2004; 183:1405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luciano DE, Exacoustos C, Johns DA, Luciano AA. Can hysterosalpingo-contrast sonography replace hysterosalpingography in confirming tubal blockage after hysteroscopic sterilization and in the evaluation of the uterus and tubes in infertile patients? Am J Obstet Gynecol 2011; 204:79.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shalev J, Meizner I, Bar-Hava I, et al. Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertility. Fertil Steril 2000; 73:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fedele L, Bianchi S, Dorta M, Vignali M. Intrauterine adhesions: detection with transvaginal US. Radiology 1996; 199:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amin TN, Saridogan E, Jurkovic D. Ultrasound and intrauterine adhesions: a novel structured approach to diagnosis and management. Ultrasound Obstet Gynecol 2015; 46:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bacelar AC, Wilcock D, Powell M, Worthington BS. The value of MRI in the assessment of traumatic intra-uterine adhesions (Asherman's syndrome). Clin Radiol 1995; 50:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dykes TA, Isler RJ, McLean AC. MR imaging of Asherman syndrome: total endometrial obliteration. J Comput Assist Tomogr 1991; 15:858.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Letterie GS, Haggerty MF. Magnetic resonance imaging of intrauterine synechiae. Gynecol Obstet Invest 1994; 37:66.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3285 Version 31.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14804168" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Traumatic intra-uterine adhesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18902559" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Amenorrhoea traumatica (atretica).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20656564" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Review of intrauterine adhesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28582327" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24082042" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21437822" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Asherman's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31515487" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Vascular endothelial growth factor 165 inhibits pro-fibrotic differentiation of stromal cells via the DLL4/Notch4/smad7 pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23826415" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Role of angiogenesis in endometrial repair of patients with severe intrauterine adhesion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17681324" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18937941" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Uterine synechiae after bipolar hysteroscopic resection of submucosal myomas in patients with infertility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27062103" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The incidence of post-operative adhesion following transection of uterine septum: a cohort study comparing three different adjuvant therapies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27261221" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Intrauterine Adhesions Following Miscarriage: Look and Learn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27436757" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Prevalence of intrauterine adhesions after termination of pregnancy: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24332096" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Hysteroscopic management of retained products of conception: meta-analysis and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26453977" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25527235" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27382236" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Effect of myomectomy on endometrial cavity: A prospective study of 51 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6126446" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The incidence of intrauterine adhesions following spontaneous abortion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13820611" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The incidence of uterine atresia after post-partum curettage. A follow-up examination of 141 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21549641" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Management of Asherman's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11703193" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Intrauterine adhesions. An update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18063608" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Hysteroscopic myomectomy: a comprehensive review of surgical techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10924629" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17686478" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Office hysteroscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24182410" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Does cold loop hysteroscopic myomectomy reduce intrauterine adhesions? A retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24484072" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Asherman syndrome in a Danish population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27773811" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Prevalence and Impact of Chronic Endometritis in Patients With Intrauterine Adhesions: A Prospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1158622" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Puerperal endometritis and intrauterine adhesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3371491" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and intrauterine adhesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17653564" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Genital tuberculosis: an important cause of Asherman's syndrome in India.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10438408" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Total corporal synechiae due to tuberculosis carry a very poor prognosis following hysteroscopic synechialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21199289" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Risk of synechiae following uterine compression sutures in the management of major postpartum haemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24380610" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Reproductive performance after conservative surgical treatment of postpartum hemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20883989" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Synechia after uterine compression sutures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23163583" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Risk of postpartum uterine synechiae following uterine compression suturing during postpartum haemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26428306" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Results of centralized Asherman surgery, 2003-2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6281085" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Intrauterine adhesions: an updated appraisal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17204526" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18406834" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Asherman syndrome--one century later.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25505226" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Diagnostic accuracy of saline infusion sonography in the evaluation of uterine cavity abnormalities prior to assisted reproductive techniques: a systematic review and meta-analyses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32497612" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Genital tuberculosis screening at an academic fertility center in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/637078" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Hysteroscopic management of intrauterine adhesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3381869" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11014950" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : A clinicohysteroscopic scoring system of intrauterine adhesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6825866" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Diagnosis and treatment of intrauterine adhesions by microhysteroscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6825866" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Diagnosis and treatment of intrauterine adhesions by microhysteroscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6825866" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Diagnosis and treatment of intrauterine adhesions by microhysteroscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28473177" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : AAGL Practice Report: Practice Guidelines on Intrauterine Adhesions Developed in Collaboration With the European Society of Gynaecological Endoscopy (ESGE).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32462368" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Magnetic resonance imaging of the female pelvis after Cesarean section: a pictorial review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10685551" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15505312" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Diagnostic value of hysterosalpingography in the detection of intrauterine abnormalities: a comparison with hysteroscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21187197" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Can hysterosalpingo-contrast sonography replace hysterosalpingography in confirming tubal blockage after hysteroscopic sterilization and in the evaluation of the uterus and tubes in infertile patients?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10685552" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8638001" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Intrauterine adhesions: detection with transvaginal US.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26094824" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Ultrasound and intrauterine adhesions: a novel structured approach to diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7867273" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : The value of MRI in the assessment of traumatic intra-uterine adhesions (Asherman's syndrome).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1885813" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : MR imaging of Asherman syndrome: total endometrial obliteration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8125415" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Magnetic resonance imaging of intrauterine synechiae.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
